Abstract
Purpose
The purpose of the study was to compare the individual and total number of symptoms and explore symptom clusters by hyperglycemia status in colorectal cancer survivors (CRCS) with diabetes (type 2).
Methods
A retrospective cohort study was conducted, whereby symptom data were extracted from clinical notes in electronic health records. CRCS (stage II or III) diagnosed between 2007 and 2017 who had diabetes and at least one HbA1c within 8 months of initial chemotherapy were included. Zero-inflated negative binomial regression analysis was used to examine total symptoms by hyperglycemia status (hyperglycemia versus no hyperglycemia). Exploratory factor analysis was conducted to identify symptom clusters.
Results
Two hundred forty-three CRCS met inclusion criteria. CRCS with hyperglycemia (HbA1c ≥ 6.5%) had greater individual symptoms (fatigue and depression) and total number of symptoms than those with no hyperglycemia. Two distinct symptom clusters, with five (nausea, vomiting, constipation, fatigue, and peripheral neuropathy) and two symptoms (anxiety and depression), were identified among CRCS with hyperglycemia.
Conclusion
These findings indicate that CRCS with diabetes and hyperglycemia had more symptoms and two distinct symptom clusters compared to those with no hyperglycemia. Prospective research studies are needed to examine the role of hyperglycemia in symptoms among CRCS with diabetes. Understanding hyperglycemia’s influence is important as it is a modifiable risk factor towards which prevention and intervention can be directed, potentially mitigating symptoms and symptom clusters and improving outcomes for CRCS with diabetes.
Similar content being viewed by others
References
González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A, DiabetesCancerConnect Consortium (2017) 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 8:18456–18485. https://doi.org/10.18632/oncotarget.14472
Storey S, Zhang Z, Luo X, Von Ah D, Metzger M, Zhang J, Jakka A, Huang K (2021) Association of comorbid diabetes with clinical outcomes and healthcare utilization in colorectal cancer survivors. Oncol Nurs Forum 48(2):195–206. https://doi.org/10.1188/21.ONF.195-206
Committee ADAPP, Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D (2022) 6. Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care 45:S83–S96. https://doi.org/10.2337/dc22-S006
Hammer MJ, Eckardt P, Cartwright F, Miaskowski C (2021) Prescribed walking for glycemic control and symptom management in patients without diabetes undergoing chemotherapy. Nurs Res 70(1):6–14. https://doi.org/10.1097/NNR.0000000000000468
Hammer M, Storey S, Hershey DS, Brady VJ, Davis E, Mandolfo N, Bryant AL, Olausson J (2019) Hyperglycemia and cancer: a state-of-the-science review. Oncol Nurs Forum 46(4):459–472. https://doi.org/10.1188/19.ONF.459-472
Luo X, Storey S, Gandhi P, Zhang Z, Metzger M, Huang K (2021) Analyzing the symptoms in colorectal and breast cancer patients with or without type 2 diabetes using EHR data. Health Inform J 27(1):14604582211000785. https://journals.sagepub.com/doi/full/10.1177/14604582211000785?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org. Accessed 21 Apr 2022
Vissers PA, Thong MS, Pouwer F, Oudsten BL, Nieuwenhuijze GA, Poll-Franse LV (2014) The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry. Support Care Cancer 22(11):3071–3079. https://doi.org/10.1007/s00520-014-2292-2
Hershey DS, Pierce SJ (2015) Examining patterns of multivariate, longitudinal symptom experiences among older adults with type 2 diabetes and cancer via cluster analysis. Eur J Oncol Nurs 19(6):716–723. https://doi.org/10.1016/j.ejon.2015.05.006
Storey S, Cohee A, Gathirua-Mwangi WG, Vachon E, Monahan P, Otte J, Stump TE, Cella D, Champion V (2019) Impact of diabetes on the symptoms of breast cancer survivors. Oncol Nurs Forum 46(4):473–484. https://doi.org/10.1188/19.ONF.473-484
McDonald CJ, Overhage JM, Barnes M, Schadow G, Blevins L, Dexter PR, Mamlin B, INPC Management Committee (2005) The Indiana network for patient care: a working local health information infrastructure. An example of a working infrastructure collaboration that links data from five health systems and hundreds of millions of entries. Health Aff (Millwood) 24(5):1214–1220. https://doi.org/10.1377/hlthaff.24.5.1214
Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337–350. https://doi.org/10.3322/caac.21342
Suo M, Wen D, Wang W, Zhang T (2020) Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with type 2 diabetes mellitus. Biosci Rep 40(5):BSR20192300. https://doi.org/10.1042/BSR20192300
Brady VJ, Grimes D, Armstrong T, LoBiondo-Wood G (2014) Management of steroid-induced hyperglycemia in hospitalized patients with cancer: a review. Oncol Nurs Forum 41(6):E355–E365. https://doi.org/10.1188/14.ONF.E355-E365
Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173(6):676–682. https://doi.org/10.1093/aje/kwq433
Gandhi P, Luo X, Storey S, Zhang Z, Han Z, Huang K. (2019). Identifying symptom clusters in breast cancer and colorectal cancer patients using EHR data. In Proceed of the 10th ACM InteConf Bioinform, Comput Biol Health Inform 405–413). https://www.semanticscholar.org/paper/Analyzing-the-symptoms-in-colorectal-and-breast-or-Luo-Storey/ae42d5d1ab823f9640008f49bf19df4653ca7070. Accessed 21 Apr 2022
Aronson AR, Lang FM. (2010) An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc 17(3):229–236. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995713/. Accessed 22 Apr 2022
Greene WH (1994) Accounting for excess zeros and sample selection in Poisson and negative binomial regression models. Econ Work Papers. http://hdl.handle.net/2451/26263. Accessed 28 Apr 2022
Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ (1999) Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 4(3):272–299. https://doi.org/10.1037/1082-989X.4.3.272
Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C, Rodriguez-Artalejo F, Martínez-Vizcaíno V (2017) Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open 7(7):e015949. https://doi.org/10.1136/bmjopen-2017-015949
Palta P, Huang ES, Kalyani RR, Golden SH, Yeh HC (2017) Hemoglobin A1c and mortality in older adults with and without diabetes: results from the National Health and Nutrition Examination Surveys (1988–2011). Diabetes Care 40(4):453–460. https://doi.org/10.2337/dci16-0042
Tseng PH, Lee YC, Chiu HM, Chen CC, Liao WC, Tu CH, Yang WS, Wu MS (2012) Association of diabetes and HbA1c levels with gastrointestinal manifestations. Diabetes Care 35(5):1053–1060. https://doi.org/10.2337/dc11-1596
Park H, Park C, Quinn L, Fritschi C (2015) Glucose control and fatigue in type 2 diabetes: the mediating roles of diabetes symptoms and distress. J Adv Nurs 71(7):1650–1660. https://doi.org/10.1111/jan.12632
Fritschi C, Park C, Quinn L, Collins EG (2020) Real-time associations between glucose levels and fatigue in type 2 diabetes: sex and time effects. Biol Res Nurs 22(2):197–204. https://doi.org/10.1177/1099800419898002
Hammer MJ, Aouizerat BE, Schmidt BL, Cartwright F, Wright F, Miaskowski C (2015) Glycosylated hemoglobin A1c and lack of association with symptom severity in patients undergoing chemotherapy for solid tumors. Oncol Nurs Forum 42(6):581–590. https://doi.org/10.1188/15.ONF.581-590
Liu X, Haagsma J, Sijbrands E, Buijks H, Boogaard L, Mackenbach JP, Erasmus V, Polinder S (2020) Anxiety and depression in diabetes care: longitudinal associations with health-related quality of life. Sci Rep 10(1):8307. https://doi.org/10.1038/s41598-020-57647-x
Jung A, Du Y, Nübel J, Busch MA, Heidemann C, Scheidt-Nave C, Baumert J (2021) Are depressive symptoms associated with quality of care in diabetes? Finding from a nationwide population-based study. BMJ Open Diabetes Res Care 9(1):e001804. https://doi.org/10.1136/bmjdrc-2020-001804
Nascimento ER, Nardi AE, Cardoso A (2014) The role of depression on glycemic control. J Endocrinol Metab 4(5):119–120. https://doi.org/10.14740/jem247w
Agasi-Idenburg SC, Thong MS, Punt CJ, Stuiver MM, Aaronson NK (2017) Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer. Support Care Cancer 25(2):625–632. https://doi.org/10.1007/s00520-016-3451-4
Hao J, Gu L, Liu P, Zhang L, Xu H, Qiu Q, Zhang W (2021) Symptom clusters in patients with colorectal cancer after colostomy: a longitudinal study in Shanghai. J Int Med Res 49(12):3000605211063105. https://doi.org/10.1177/03000605211063105
de Mello MRSP, Moura SF, Muzi CD, GuimarÃes RM (2020) Clinical evaluation and pattern of symptoms in colorectal cancer patients. Arq Gastroenterol 57(2):131–136. https://doi.org/10.1590/s0004-2803.202000000-24
Han CJ, Reding K, Cooper BA, Paul SM, Conley YP, Hammer M, Kober KM, Levine JD, Miaskowski C (2019) Stability of symptom clusters in patients with gastrointestinal cancers receiving chemotherapy. J Pain Symptom Manage 58(6):989-1001.e10. https://doi.org/10.1016/j.jpainsymman.2019.07.029
Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ (2003) Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults. Am J Gastroenterol 98(2):391–398. https://doi.org/10.1016/S0002-9270(02)05904-X
Frankum S, Ogden J (2005) Estimation of blood glucose levels by people with diabetes: a cross-sectional study. Br J Gen Pract 55(521):944–948
Chang SC, Yang WV (2016) Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol 108:146–153. https://doi.org/10.1016/j.critrevonc.2016.11.003
Miaskowski C, Barsevick A, Berger A, Casagrande R, Grady PA, Jacobsen P, Kutner J, Patrick D, Zimmerman L, **ao C, Matocha M, Marden S (2017) Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst 109(4):djw253. https://doi.org/10.1093/jnci/djw253
Fayyaz B, Rehman HJ, Minn H (2019) Interpretation of hemoglobin A1c in primary care setting. J Community Hosp Intern Med Perspect 9(1):18–21. https://doi.org/10.1080/20009666.2018.1559432
** HY, Lee KA, Park TS (2016) The impact of glycemic variability on diabetic peripheral neuropathy. Endocrine 53:643–648. https://doi.org/10.1007/s12020-016-1005-7
Hershey DS (2017) Importance of glycemic control in cancer patients with diabetes: treatment through end of life. Asia Pac J Oncol Nurs 4:313–318. https://doi.org/10.4103/apjon.apjon_40_17
Hammer MJ, D’EramoMelkus G, Knobf MT, Casper C, Fletcher J, Cleland CM (2016) Glycemic status and infection risk in nondiabetic autologous hematopoietic cell transplantation recipients. Biol Res Nurs 18(3):344–350. https://doi.org/10.1177/1099800415619227
Storey S, Von Ah D, Hammer MJ (2017) Measurement of hyperglycemia and impact on health outcomes in people with cancer: challenges and opportunities. Oncol Nurs Forum 44(4):E141–E151. https://doi.org/10.1188/17.ONF.E141-E151
Hammer MJ, Casper C, Gooley TA, O’Donnell PV, Boeckh M, Hirsch IB (2009) The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 15(3):344–351. https://doi.org/10.1016/j.bbmt.2008.12.488
Hammer MJ, Paul SM, Steinberg A, Eckardt P, Barton-Burke M, Miaskowski C (2019) Trajectories of fasting blood glucose in autologous hematopoietic cell transplantation. Cancer Nurs 42(4):307–313. https://doi.org/10.1097/NCC.0000000000000627
Funding
This study was supported by an Oncology Nursing Foundation RE01 grant and an Indiana University Simon Cancer Center, Cancer Prevention and Control Pilot grant (PI Storey).
Author information
Authors and Affiliations
Contributions
All authors contributed to this manuscript: study conception and design (Storey, Von Ah, Luo, and Perkins); acquisition of data (Luo); data analysis (Ofner and Perkins); data interpretation (Storey, Von Ah, Ofner, and Perkins); and writing and revising (Storey, Von Ah, Luo, Ofner, and Perkins). All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Indiana University (Date February 19, 2021, No. 10526).
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key message
This innovative study examined the role of hyperglycemia in symptoms and symptom clusters among colorectal cancer survivors (CRCS) with diabetes. We found that CRCS with diabetes and hyperglycemia had more symptoms and two distinct symptom clusters. Prospective research is needed to confirm these findings.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Storey, S., Luo, X., Ofner, S. et al. Hyperglycemia, symptoms, and symptom clusters in colorectal cancer survivors with type 2 diabetes. Support Care Cancer 30, 10149–10157 (2022). https://doi.org/10.1007/s00520-022-07442-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-07442-3